The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for in Vitro Fertilization
Open accessAbstract
In a randomized multicenter study, the efficacies of two different GnRH agonists were compared with that of hCG for triggering final stages of oocyte maturation after ovarian hyperstimulation for in vitro fertilization. Ovarian stimulation was conducted by recombinant FSH (Puregon), and the GnRH antagonist ganirelix (Orgalutran) was coadministered for the prevention of a premature LH rise. Luteal support was provided by daily progestin administration. Frequent blood sampling was performed at midcycle in the first 47 eligible subjects included in the current study, who were randomized for a single dose of 0.2 mg triptorelin (n = 17), 0.5 mg leuprorelin (n = 15), or 10,000 IU hCG (n = 15). Serum concentrations of LH, FSH, E2, and progesterone (P) were assessed at variable intervals. LH peaked at 4 h after both triptorelin and leuprorelin administration, with median LH levels of 130 and 107 IU/liter (P < 0.001), respectively. LH levels returned to baseline after 24 h. Subjects receiving hCG showed peak levels of 240 IU/liter hCG 24 h after administration. A rise in FSH to 19 IU/liter (P < 0.001) was noted in both GnRH agonist groups 8 h after injection. Within 24 h the areas under the curve for LH and FSH were significantly higher (P < 0.001) in both GnRH agonist groups compared with that for hCG. E2 and P levels were similar for all groups up to the day of oocyte retrieval. Luteal phase areas under the curve for P and E2 were significantly elevated (P < 0.001) in the hCG group. The mean (+/-SD) numbers of oocytes retrieved were 9.8 +/- 5.4, 8.7 +/- 4.5, and 8.3 +/- 3.3; the percentages of metaphase II oocytes were 72%, 85%, and 86%; and fertilization rates were 61%, 62%, and 56% in the triptorelin, leuprorelin, and hCG group, respectively (P = NS for all three comparisons). These findings support the effective induction of final oocyte maturation in both GnRH agonist groups. In summary, after treatment with the GnRH antagonist ganirelix for the prevention of premature LH surges, triggering of final stages of oocyte maturation can be induced effectively by a single bolus injection of GnRH agonist, as demonstrated by the induced endogenous LH and FSH surge and the quality and fertilization rate of recovered oocytes. Moreover, corpus luteum formation is induced by GnRH agonists with luteal phase steroid levels closer to the physiological range compared with hCG. This more physiological approach for inducing oocyte maturation may represent a successful and safer alternative for in vitro fertilization patients undergoing ovarian hyperstimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormonal Dynamics at Midcycle: A Reevaluation*
HOFF, J. D., QUIGLEY, M. E., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-792 · Cited by 525
The European Orgalutran® Study Group, Borm, G., & Mannaerts, B. (2000) · Human Reproduction · doi:10.1093/humrep/15.7.1490 · Cited by 376
The ovarian hyperstimulation syndrome
Whelan, J. G., & Vlahos, N. F. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00491-x · Cited by 363
Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L., & Brandes, J. M. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54474-4 · Cited by 311
Distinction between early and late ovarian hyperstimulation syndrome
Mathur, R. S., Akande, A. V., Keay, S. D., Hunt, L. P., & Jenkins, J. M. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00492-1 · Cited by 281
The pathophysiology of ovarian hyperstimulation syndrome--views and ideas
Elchalal, U., & Schenker, J. G. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1129 · Cited by 241
Simón, C., Garcia Velasco, J. J., Valbuena, D., Peinado, J. A., Moreno, C., Remohí, J., & Pellicer, A. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00140-x · Cited by 235
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks
Fauser, B. C. J. M., Devroey, P., Yen, S. S. C., Gosden, R., Crowley, W. F., Baird, D. T., & Bouchard, P. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2681 · Cited by 221
Self-citationThe role of luteal phase support in infertility treatment: a meta-analysis of randomized trials
Soliman, S., Salim Daya, M. B., Collins, J., & Hughes, E. G. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56758-2 · Cited by 194
Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation
Forman, R., Belaisch-Allart, J., Fries, N., Hazout, A., Testart, J., & Frydman, R. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59661-7 · Cited by 191
Zelinski-Wooten, M. B., Hutchison, J. S., Hess, D. L., Wolf, D. P., & Stouffer, R. L. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136151 · Cited by 187
Disappearance of exogenously administered human chorionic gonadotropin
Damewood, M. D., Shen, W., Zacur, H. A., Schlaff, W. D., Rock, J. A., & Wallach, E. E. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60906-8 · Cited by 174
Sullivan, M. W., Stewart-Akers, A., Krasnow, J. S., Berga, S. L., & Zeleznik, A. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5389 · Cited by 170
Enskog, A., Henriksson, M., Unander, M., Nilsson, L., & Brännström, M. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00090-4 · Cited by 165
Wallach, E. E., Shoham, Z., Schachter, M. E., Loumaye, E., Weissman, A., Macnamee, M. C., & Insler, V. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57717-6 · Cited by 141
Galway, A., LaPolt, P. S., TSAFRIRI, A., et al. (1990) · Endocrinology · doi:10.1210/endo-127-6-3023 · Cited by 103
Olivennes, F. J., Fanchin, R. R. F., Bouchard, P., Taieb, J., & Frydman, R. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58404-0 · Cited by 100
Oberyé, J., Mannaerts, B. M. J. L., Huisman, J., & Timmer, C. J. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00414-8 · Cited by 98
Emperaire, J.-C., & Ruffié, A. (1991) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137368 · Cited by 77
Oberyé, J., Mannaerts, B. M. J. L., Kleijn, H. J., & Timmer, C. J. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00413-6 · Cited by 68
Mochtar, M. H., Hogerzeil, H. V., & Mol, B. W. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019453 · Cited by 64
Porchet, H. C., le Cotonnec, J.-Y., Neuteboom, B., Canali, S., & Zanolo, G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.2.667 · Cited by 45
Zelinski, M. B., Hutchison, J. S., Chandrasekher, Y. A., et al. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639951 · Cited by 45
Moffatt, O., Drury, S. L., Tomlinson, M., Afnan, M., & Sakkas, D. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02951-5 · Cited by 40
Nature and bioactivity of gonadotropin-releasing hormone (GnRH) secreted during the GnRH surge
Caraty, A., Antoine, C., Delaleu, B., Locatelli, A., Bouchard, P., Gautron, J.-P., Evans, N. P., Karsch, F. J., & Padmanabhan, V. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628381 · Cited by 40
Female infertility therapy : current practice
Shoham, Z., Howles, C. M., & Jacobs, H. S. (1999) · Martin Dunitz eBooks · Cited by 35
Gonadotropin-releasing hormone antagonist: new tools vs. old habits
Bouchard, P., & Fauser, B. C. J. M. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00446-x · Cited by 32
Self-citationShort-term modulation of gonadotropin secretion by progesterone during the luteal phase
Gibson, M., Nakajima, S. T., & McAuliffe, T. L. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54179-x · Cited by 23
Cited by
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
Delvigne, A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.559 · Cited by 717
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Self-citationHumaidan, P., Ejdrup Bredkjær, H., Bungum, L., Bungum, M., Grøndahl, M. L., Westergaard, L., & Yding Andersen, C. (2005) · Human Reproduction · doi:10.1093/humrep/deh765 · Cited by 484
Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008046.pub4 · Cited by 426
Engmann, L., DiLuigi, A., Schmidt, D., Nulsen, J., Maier, D., & Benadiva, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.002 · Cited by 422
Metadata
- Authors
- Fauser, B. C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-02-01
- Volume
- 87
- Issue
- 2
- Pages
- 709-715
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2146771682
- Cited by
- 343
- References
- 28
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.